SynthesisBMC musculoskeletal disorders2025
Foot and ankle angioleiomyoma: a systematic review.
Synthesis in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Diagnostic Challenge: An Extremely Rare Case of Intra-Articular Myopericytoma of the Knee.Diagnostics (Basel, Switzerland) · 2026Article
- Preoperative Differentiation of Non-Subungual Glomus Tumors from Other Superficial Soft Tissue Tumors Using a Clinical and Ultrasound-Based Model.Biomedicines · 2025Article
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAngioleiomyoma is a benign tumor arising from smooth muscle that is commonly found in the foot and ankle. This systematic review aims to synthesize the limited data from numerous case reports and case series, which often involve small sample sizes, to provide orthopaedic surgeons with a comprehensive overview of the diagnosis and management of foot and ankle angioleiomyoma.
methodsThis systematic review, performed following the PRISMA guidelines, brings updated information for the diagnosis and management of foot and ankle angioleiomyoma. 62 relevant studies were included. We analysed patient demographics, clinical characteristics, diagnostic workup, treatment, and clinical outcomes.
resultsAngioleiomyoma is more prevalent in middle-aged women, and pain is the most common symptom. Its diagnosis is often delayed due to its rarity and nonspecific presentation. Plain radiographs, MRI, and ultrasound of the foot and ankle are the most common preoperative imaging exams. Surgical excision is the treatment of choice with a low rate of both recurrence and malignant transformation.
conclusionsThis review emphasizes the importance of considering angioleiomyoma in the differential diagnosis of foot and ankle tumors and highlights the need for a comprehensive workup to improve diagnostic accuracy and ensure appropriate management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.